Structure

Physi-Chem Properties

Molecular Weight:  370.21
Volume:  394.117
LogP:  4.573
LogD:  3.722
LogS:  -4.782
# Rotatable Bonds:  1
TPSA:  63.6
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.732
Synthetic Accessibility Score:  4.297
Fsp3:  0.652
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.033
MDCK Permeability:  1.9920147678931244e-05
Pgp-inhibitor:  0.057
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.841

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.325
Plasma Protein Binding (PPB):  90.03544616699219%
Volume Distribution (VD):  1.217
Pgp-substrate:  6.677754878997803%

ADMET: Metabolism

CYP1A2-inhibitor:  0.221
CYP1A2-substrate:  0.869
CYP2C19-inhibitor:  0.159
CYP2C19-substrate:  0.863
CYP2C9-inhibitor:  0.216
CYP2C9-substrate:  0.899
CYP2D6-inhibitor:  0.137
CYP2D6-substrate:  0.451
CYP3A4-inhibitor:  0.339
CYP3A4-substrate:  0.52

ADMET: Excretion

Clearance (CL):  14.519
Half-life (T1/2):  0.38

ADMET: Toxicity

hERG Blockers:  0.024
Human Hepatotoxicity (H-HT):  0.264
Drug-inuced Liver Injury (DILI):  0.05
AMES Toxicity:  0.027
Rat Oral Acute Toxicity:  0.319
Maximum Recommended Daily Dose:  0.835
Skin Sensitization:  0.128
Carcinogencity:  0.21
Eye Corrosion:  0.004
Eye Irritation:  0.624
Respiratory Toxicity:  0.973

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC272196

Natural Product ID:  NPC272196
Common Name*:   Phomoarcherin C
IUPAC Name:   (4aR,6aS,12aR,12bS)-11-hydroxy-4,4,6a,9,12b-pentamethyl-3-oxo-2,4a,5,6,12,12a-hexahydro-1H-benzo[a]xanthene-8-carbaldehyde
Synonyms:   Phomoarcherin C
Standard InCHIKey:  JDDYDTDIIFQNAG-WKZKVMAPSA-N
Standard InCHI:  InChI=1S/C23H30O4/c1-13-10-16(25)14-11-18-22(4)8-7-19(26)21(2,3)17(22)6-9-23(18,5)27-20(14)15(13)12-24/h10,12,17-18,25H,6-9,11H2,1-5H3/t17-,18+,22-,23-/m0/s1
SMILES:  O=Cc1c(C)cc(c2c1O[C@@]1(C)CC[C@@H]3[C@]([C@H]1C2)(C)CCC(=O)C3(C)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1773757
PubChem CID:   52952105
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0001612] Isoflavans
          • [CHEMONTID:0001828] Isoflavanols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16660 Phomopsis archeri Species Valsaceae Eukaryota n.a. mycelium n.a. PMID[21341709]
NPO16660 Phomopsis archeri Species Valsaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 8.9 ug.mL-1 PMID[480183]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 18.0 ug.mL-1 PMID[480183]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 15.4 ug.mL-1 PMID[480183]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 18.8 ug.mL-1 PMID[480183]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC272196 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9427 High Similarity NPC125465
0.9416 High Similarity NPC472617
0.9404 High Similarity NPC149526
0.9404 High Similarity NPC478148
0.9404 High Similarity NPC474417
0.9355 High Similarity NPC472618
0.9342 High Similarity NPC87708
0.9299 High Similarity NPC100849
0.9286 High Similarity NPC4547
0.9281 High Similarity NPC329844
0.9276 High Similarity NPC232645
0.9276 High Similarity NPC305965
0.9276 High Similarity NPC72958
0.9262 High Similarity NPC470674
0.9262 High Similarity NPC117716
0.9262 High Similarity NPC470673
0.9216 High Similarity NPC40356
0.9216 High Similarity NPC154683
0.92 High Similarity NPC470676
0.92 High Similarity NPC473135
0.92 High Similarity NPC473132
0.9156 High Similarity NPC169990
0.9156 High Similarity NPC210942
0.9156 High Similarity NPC472799
0.915 High Similarity NPC470675
0.915 High Similarity NPC473131
0.9145 High Similarity NPC158338
0.9145 High Similarity NPC100985
0.9145 High Similarity NPC97028
0.9145 High Similarity NPC329933
0.9145 High Similarity NPC65589
0.9145 High Similarity NPC97029
0.9145 High Similarity NPC288036
0.9139 High Similarity NPC34802
0.9114 High Similarity NPC473022
0.9085 High Similarity NPC202595
0.9085 High Similarity NPC150928
0.9079 High Similarity NPC7025
0.9079 High Similarity NPC27221
0.9079 High Similarity NPC256672
0.9051 High Similarity NPC18380
0.9051 High Similarity NPC137232
0.9045 High Similarity NPC195167
0.902 High Similarity NPC473016
0.902 High Similarity NPC471114
0.9013 High Similarity NPC123202
0.9013 High Similarity NPC22005
0.9013 High Similarity NPC10990
0.9013 High Similarity NPC300988
0.9013 High Similarity NPC7943
0.9013 High Similarity NPC245757
0.9013 High Similarity NPC304351
0.9007 High Similarity NPC271288
0.9006 High Similarity NPC472622
0.9 High Similarity NPC310340
0.8994 High Similarity NPC15374
0.8987 High Similarity NPC292863
0.8987 High Similarity NPC184326
0.8987 High Similarity NPC470810
0.8981 High Similarity NPC158542
0.8981 High Similarity NPC44199
0.8974 High Similarity NPC89625
0.8974 High Similarity NPC149618
0.8968 High Similarity NPC217447
0.8961 High Similarity NPC472633
0.8961 High Similarity NPC470568
0.8961 High Similarity NPC325983
0.8961 High Similarity NPC158866
0.8961 High Similarity NPC29777
0.8961 High Similarity NPC471115
0.8954 High Similarity NPC35150
0.8954 High Similarity NPC106328
0.8947 High Similarity NPC196114
0.8947 High Similarity NPC290133
0.8947 High Similarity NPC24136
0.8947 High Similarity NPC187282
0.8947 High Similarity NPC477955
0.8944 High Similarity NPC472621
0.8938 High Similarity NPC12461
0.8933 High Similarity NPC96692
0.8924 High Similarity NPC474373
0.8924 High Similarity NPC186113
0.8924 High Similarity NPC85121
0.891 High Similarity NPC214632
0.891 High Similarity NPC280530
0.891 High Similarity NPC95842
0.891 High Similarity NPC178964
0.891 High Similarity NPC135522
0.891 High Similarity NPC208806
0.8903 High Similarity NPC178484
0.8903 High Similarity NPC470569
0.8896 High Similarity NPC291049
0.8896 High Similarity NPC10027
0.8896 High Similarity NPC65775
0.8896 High Similarity NPC233267
0.8896 High Similarity NPC474052
0.8896 High Similarity NPC473978
0.8889 High Similarity NPC118027
0.8889 High Similarity NPC296998
0.8889 High Similarity NPC289042
0.8889 High Similarity NPC225419
0.8889 High Similarity NPC56433
0.8889 High Similarity NPC245584
0.8889 High Similarity NPC473077
0.8889 High Similarity NPC190648
0.8889 High Similarity NPC312929
0.8889 High Similarity NPC126767
0.8889 High Similarity NPC308200
0.8882 High Similarity NPC316262
0.8882 High Similarity NPC131568
0.8882 High Similarity NPC131579
0.8882 High Similarity NPC314653
0.8875 High Similarity NPC206605
0.8875 High Similarity NPC473961
0.8875 High Similarity NPC475106
0.8874 High Similarity NPC84266
0.8868 High Similarity NPC186325
0.8868 High Similarity NPC476280
0.8868 High Similarity NPC297212
0.8867 High Similarity NPC469818
0.8867 High Similarity NPC477272
0.8867 High Similarity NPC275734
0.8861 High Similarity NPC282390
0.8861 High Similarity NPC196448
0.8861 High Similarity NPC281137
0.8861 High Similarity NPC201127
0.8859 High Similarity NPC470671
0.8859 High Similarity NPC474504
0.8859 High Similarity NPC470672
0.8859 High Similarity NPC474487
0.8846 High Similarity NPC142527
0.8846 High Similarity NPC470338
0.8846 High Similarity NPC268992
0.8846 High Similarity NPC470337
0.8846 High Similarity NPC273483
0.8846 High Similarity NPC51824
0.8846 High Similarity NPC113608
0.8839 High Similarity NPC227122
0.8839 High Similarity NPC188403
0.8839 High Similarity NPC255641
0.8839 High Similarity NPC147735
0.8839 High Similarity NPC290954
0.8834 High Similarity NPC472619
0.8831 High Similarity NPC145467
0.8831 High Similarity NPC105415
0.8831 High Similarity NPC37139
0.8831 High Similarity NPC39195
0.8827 High Similarity NPC43319
0.8827 High Similarity NPC272502
0.8824 High Similarity NPC82534
0.8824 High Similarity NPC109183
0.8824 High Similarity NPC54577
0.8824 High Similarity NPC195621
0.8824 High Similarity NPC475052
0.8824 High Similarity NPC267375
0.8824 High Similarity NPC214774
0.8824 High Similarity NPC473078
0.8824 High Similarity NPC470647
0.8824 High Similarity NPC301276
0.8824 High Similarity NPC470132
0.8824 High Similarity NPC127059
0.8824 High Similarity NPC312973
0.8824 High Similarity NPC470131
0.8824 High Similarity NPC20488
0.8824 High Similarity NPC67805
0.8824 High Similarity NPC142405
0.8824 High Similarity NPC176229
0.8824 High Similarity NPC88964
0.8824 High Similarity NPC285630
0.8824 High Similarity NPC111786
0.8824 High Similarity NPC470134
0.8824 High Similarity NPC246948
0.8824 High Similarity NPC83357
0.8824 High Similarity NPC470133
0.882 High Similarity NPC290160
0.882 High Similarity NPC476295
0.8816 High Similarity NPC166138
0.8816 High Similarity NPC5990
0.8816 High Similarity NPC316816
0.8816 High Similarity NPC214166
0.8816 High Similarity NPC11700
0.8816 High Similarity NPC85162
0.8816 High Similarity NPC125894
0.8816 High Similarity NPC478086
0.8816 High Similarity NPC278249
0.8816 High Similarity NPC18585
0.8816 High Similarity NPC106985
0.8816 High Similarity NPC77794
0.8816 High Similarity NPC107177
0.8816 High Similarity NPC223812
0.8816 High Similarity NPC81697
0.8816 High Similarity NPC219915
0.8816 High Similarity NPC189650
0.8812 High Similarity NPC189552
0.8812 High Similarity NPC472906
0.8812 High Similarity NPC273467
0.8808 High Similarity NPC166689
0.8808 High Similarity NPC156190
0.8808 High Similarity NPC17170
0.8808 High Similarity NPC96408

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC272196 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8931 High Similarity NPD6959 Discontinued
0.8734 High Similarity NPD8443 Clinical (unspecified phase)
0.8671 High Similarity NPD7819 Suspended
0.86 High Similarity NPD6100 Approved
0.86 High Similarity NPD6099 Approved
0.8553 High Similarity NPD2393 Clinical (unspecified phase)
0.8516 High Similarity NPD7410 Clinical (unspecified phase)
0.8516 High Similarity NPD4378 Clinical (unspecified phase)
0.8428 Intermediate Similarity NPD7411 Suspended
0.8421 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8421 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8397 Intermediate Similarity NPD2534 Approved
0.8397 Intermediate Similarity NPD2532 Approved
0.8397 Intermediate Similarity NPD2533 Approved
0.8366 Intermediate Similarity NPD1549 Phase 2
0.8366 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8263 Intermediate Similarity NPD7473 Discontinued
0.8261 Intermediate Similarity NPD1934 Approved
0.8258 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.825 Intermediate Similarity NPD4380 Phase 2
0.8204 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8194 Intermediate Similarity NPD2800 Approved
0.8193 Intermediate Similarity NPD6232 Discontinued
0.8171 Intermediate Similarity NPD7075 Discontinued
0.8171 Intermediate Similarity NPD3749 Approved
0.817 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.817 Intermediate Similarity NPD1510 Phase 2
0.8166 Intermediate Similarity NPD5844 Phase 1
0.8158 Intermediate Similarity NPD1607 Approved
0.8137 Intermediate Similarity NPD6599 Discontinued
0.8117 Intermediate Similarity NPD2796 Approved
0.811 Intermediate Similarity NPD7768 Phase 2
0.8101 Intermediate Similarity NPD7390 Discontinued
0.8098 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD6166 Phase 2
0.8095 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD5494 Approved
0.8039 Intermediate Similarity NPD6651 Approved
0.8026 Intermediate Similarity NPD1240 Approved
0.8025 Intermediate Similarity NPD3750 Approved
0.8023 Intermediate Similarity NPD6559 Discontinued
0.8 Intermediate Similarity NPD1551 Phase 2
0.7988 Intermediate Similarity NPD2801 Approved
0.7987 Intermediate Similarity NPD1511 Approved
0.7963 Intermediate Similarity NPD3226 Approved
0.7952 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7937 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD3882 Suspended
0.7888 Intermediate Similarity NPD1512 Approved
0.787 Intermediate Similarity NPD5711 Approved
0.787 Intermediate Similarity NPD5710 Approved
0.7853 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7848 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7834 Intermediate Similarity NPD2346 Discontinued
0.7829 Intermediate Similarity NPD4625 Phase 3
0.7818 Intermediate Similarity NPD6801 Discontinued
0.7803 Intermediate Similarity NPD7074 Phase 3
0.7764 Intermediate Similarity NPD6799 Approved
0.7763 Intermediate Similarity NPD4908 Phase 1
0.7746 Intermediate Similarity NPD7054 Approved
0.7725 Intermediate Similarity NPD3817 Phase 2
0.7722 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7707 Intermediate Similarity NPD3748 Approved
0.7701 Intermediate Similarity NPD7472 Approved
0.7688 Intermediate Similarity NPD7003 Approved
0.7688 Intermediate Similarity NPD4628 Phase 3
0.767 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD4749 Approved
0.7665 Intermediate Similarity NPD5760 Phase 2
0.7665 Intermediate Similarity NPD5761 Phase 2
0.7658 Intermediate Similarity NPD2935 Discontinued
0.7657 Intermediate Similarity NPD6797 Phase 2
0.7636 Intermediate Similarity NPD7458 Discontinued
0.7627 Intermediate Similarity NPD8312 Approved
0.7627 Intermediate Similarity NPD8313 Approved
0.7622 Intermediate Similarity NPD920 Approved
0.7614 Intermediate Similarity NPD7251 Discontinued
0.7607 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7595 Intermediate Similarity NPD2799 Discontinued
0.7593 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD3818 Discontinued
0.7571 Intermediate Similarity NPD7808 Phase 3
0.7561 Intermediate Similarity NPD6273 Approved
0.756 Intermediate Similarity NPD1465 Phase 2
0.7548 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7547 Intermediate Similarity NPD5406 Approved
0.7547 Intermediate Similarity NPD5405 Approved
0.7547 Intermediate Similarity NPD5404 Approved
0.7547 Intermediate Similarity NPD5408 Approved
0.7516 Intermediate Similarity NPD1243 Approved
0.75 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD919 Approved
0.7472 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD5953 Discontinued
0.7457 Intermediate Similarity NPD7229 Phase 3
0.7446 Intermediate Similarity NPD4360 Phase 2
0.7446 Intermediate Similarity NPD4363 Phase 3
0.7433 Intermediate Similarity NPD6781 Approved
0.7433 Intermediate Similarity NPD6779 Approved
0.7433 Intermediate Similarity NPD6780 Approved
0.7433 Intermediate Similarity NPD6776 Approved
0.7433 Intermediate Similarity NPD6782 Approved
0.7433 Intermediate Similarity NPD6777 Approved
0.7433 Intermediate Similarity NPD6778 Approved
0.7417 Intermediate Similarity NPD1201 Approved
0.7417 Intermediate Similarity NPD1610 Phase 2
0.7412 Intermediate Similarity NPD5402 Approved
0.741 Intermediate Similarity NPD5403 Approved
0.7405 Intermediate Similarity NPD5124 Phase 1
0.7405 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD8150 Discontinued
0.7403 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD8434 Phase 2
0.7399 Intermediate Similarity NPD1247 Approved
0.7391 Intermediate Similarity NPD2344 Approved
0.7386 Intermediate Similarity NPD7177 Discontinued
0.7386 Intermediate Similarity NPD3751 Discontinued
0.7362 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD3787 Discontinued
0.7345 Intermediate Similarity NPD7286 Phase 2
0.734 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD1470 Approved
0.7322 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7316 Intermediate Similarity NPD7435 Discontinued
0.7316 Intermediate Similarity NPD7697 Approved
0.7316 Intermediate Similarity NPD7698 Approved
0.7316 Intermediate Similarity NPD7696 Phase 3
0.7306 Intermediate Similarity NPD8151 Discontinued
0.7299 Intermediate Similarity NPD7199 Phase 2
0.7294 Intermediate Similarity NPD37 Approved
0.7289 Intermediate Similarity NPD5401 Approved
0.7283 Intermediate Similarity NPD6234 Discontinued
0.7277 Intermediate Similarity NPD7871 Phase 2
0.7277 Intermediate Similarity NPD7870 Phase 2
0.7267 Intermediate Similarity NPD4965 Approved
0.7267 Intermediate Similarity NPD4967 Phase 2
0.7267 Intermediate Similarity NPD4966 Approved
0.7255 Intermediate Similarity NPD3972 Approved
0.7233 Intermediate Similarity NPD943 Approved
0.7231 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7231 Intermediate Similarity NPD7783 Phase 2
0.7228 Intermediate Similarity NPD4287 Approved
0.7219 Intermediate Similarity NPD4361 Phase 2
0.7219 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD3926 Phase 2
0.7215 Intermediate Similarity NPD2313 Discontinued
0.7215 Intermediate Similarity NPD3268 Approved
0.7212 Intermediate Similarity NPD2309 Approved
0.7191 Intermediate Similarity NPD7228 Approved
0.719 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD2798 Approved
0.7173 Intermediate Similarity NPD6823 Phase 2
0.717 Intermediate Similarity NPD8032 Phase 2
0.7166 Intermediate Similarity NPD6534 Approved
0.7166 Intermediate Similarity NPD6535 Approved
0.7165 Intermediate Similarity NPD7701 Phase 2
0.7161 Intermediate Similarity NPD1283 Approved
0.7161 Intermediate Similarity NPD6696 Suspended
0.716 Intermediate Similarity NPD4308 Phase 3
0.716 Intermediate Similarity NPD7033 Discontinued
0.7158 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7801 Approved
0.7143 Intermediate Similarity NPD1608 Approved
0.7135 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7127 Intermediate Similarity NPD3658 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD4060 Phase 1
0.7115 Intermediate Similarity NPD1203 Approved
0.7115 Intermediate Similarity NPD2797 Approved
0.711 Intermediate Similarity NPD4288 Approved
0.7107 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD411 Approved
0.7107 Intermediate Similarity NPD3764 Approved
0.7105 Intermediate Similarity NPD1651 Approved
0.7101 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7092 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7092 Intermediate Similarity NPD7874 Approved
0.7091 Intermediate Similarity NPD2654 Approved
0.7091 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.709 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD6832 Phase 2
0.7086 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD230 Phase 1
0.7073 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD1471 Phase 3
0.7059 Intermediate Similarity NPD3019 Approved
0.7059 Intermediate Similarity NPD4626 Approved
0.7059 Intermediate Similarity NPD1778 Approved
0.7055 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7053 Intermediate Similarity NPD7700 Phase 2
0.7053 Intermediate Similarity NPD7699 Phase 2
0.7048 Intermediate Similarity NPD8166 Discontinued
0.7039 Intermediate Similarity NPD1548 Phase 1
0.7037 Intermediate Similarity NPD4097 Suspended

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data